Target intelligence / Profile preview

Feline allergen Fel d 7 (Fel d 7)

Target
Fel d 7
Molecular classification
Lipocalin, Other
01

Overview

Feline allergen Fel d 7 is a 17.5–18 kDa protein belonging to the lipocalin family, specifically identified as a homologue of von Ebner gland protein (VEGP) [1, 4]. It is primarily secreted by the lingual salivary glands and is found in cat saliva, tears, and on the fur [1, 3]. Fel d 7 is a clinically significant cat allergen, with sensitization rates ranging from 31% to 54% among cat-allergic individuals [1, 5]. It is associated with respiratory conditions such as asthma and allergic rhinitis, as well as atopic dermatitis [1, 13]. Notably, Fel d 7 exhibits high sequence identity (approximately 63%) and structural similarity with the major dog allergen Can f 1, leading to frequent cross-reactivity between cat and dog allergies [2, 8]. In the therapeutic landscape, Fel d 7 is a target for component-resolved diagnosis and allergen-specific immunotherapy (AIT), which aims to induce immune tolerance [12, 13]. Research is also exploring the use of neutralizing monoclonal antibodies to block IgE binding and prevent allergic symptoms [12, 14]. The protein also functions as a lipid-binding molecule, carrying ligands such as palmitic and oleic acids, which may influence its allergenicity [8, 11].

Other names
von Ebner gland proteinVEGPCat lipocalinFelis domesticus allergen 7
02

Mechanism of action

Allergen-specific immunotherapy (AIT) induces immune tolerance through the induction of regulatory T cells (Tregs) and allergen-specific IgG4 antibodies, which compete with IgE for allergen binding.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationOther
05

Safety considerations

AnaphylaxisCross-reactivity with dog allergen Can f 1
06

Interacting drugs

Cat dander allergen extract
07

Biomarkers

Fel d 7-specific IgEBasophil activation test (BAT)

Beyond the preview

Go deeper on Feline allergen Fel d 7 (Fel d 7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feline allergen Fel d 7 (Fel d 7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call